Literature DB >> 2011400

Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors.

C L Rosenberg1, H G Kim, T B Shows, H M Kronenberg, A Arnold.   

Abstract

We report the detailed molecular characterization of a human parathyroid adenoma with a clonal parathyroid hormone gene rearrangement. This rearrangement is similar to one we characterized recently in an independent adenoma. In these two, plus a third partially characterized adenoma, one allele of the PTH gene, on 11p15, is rearranged with DNA from the D11S287 region on 11q13. This region contains a transcribed sequence, D11S287E, distinct from known 11q13 oncogenes, that is expressed in all parathyroid tissues examined, but is overexpressed dramatically in all three tumours with PTH gene-D11S287 rearrangements. These findings suggest that overexpression of D11S287E, perhaps driven by the misplaced PTH gene's regulatory elements, contributed to the development of these benign tumors. D11S287E is a new candidate oncogene with potential importance in parathyroid adenomas and perhaps other tumors with 11q13 abnormalities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011400

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

Review 1.  A specific role for cyclin D1 in mammary gland development.

Authors:  P Sicinski; R A Weinberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  New gene in the homologous human 11q13-q14 and mouse 7F chromosomal regions.

Authors:  V Ollendorff; P Szepetowski; M G Mattei; P Gaudray; D Birnbaum
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma.

Authors:  Sanjay M Mallya; H Irene Wu; Elizabeth A Saria; Kristin R Corrado; Andrew Arnold
Journal:  J Bone Miner Res       Date:  2010-07-16       Impact factor: 6.741

4.  D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.

Authors:  Georgia Levidou; Angelica A Saetta; Maria Karlou; Irene Thymara; Harris Pratsinis; Petros Pavlopoulos; Dimitrios Isaiadis; Kalliopi Diamantopoulou; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-20       Impact factor: 4.553

5.  Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.

Authors:  P J van Diest; R J Michalides; L Jannink; P van der Valk; H L Peterse; J S de Jong; C J Meijer; J P Baak
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

6.  Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

Authors:  M Li; H Lee; D W Yoon; J C Albrecht; B Fleckenstein; F Neipel; J U Jung
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Function of a human cyclin gene as an oncogene.

Authors:  P W Hinds; S F Dowdy; E N Eaton; A Arnold; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer.

Authors:  J S de Jong; P J van Diest; R J Michalides; P van der Valk; C J Meijer; J P Baak
Journal:  Mol Pathol       Date:  1998-02

9.  Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms.

Authors:  J T Winston; W J Pledger
Journal:  Mol Biol Cell       Date:  1993-11       Impact factor: 4.138

10.  Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.

Authors:  E Slatopolsky; J Finch; M Denda; C Ritter; M Zhong; A Dusso; P N MacDonald; A J Brown
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.